FDA approves Roche’s new test to screen HIV, hepatitis in blood donations

The Food and Drug Administration approved Basel, Switzerland-based Roche’s cobasMPX test to be used with the cobas 6800 and 8800 systems, according to StreetInsider.

Advertisement

The cobas 6800 and 8800 systems are fully automated molecular platforms used to screen blood and plasma for various traits.

The new cobas MPX test detects HIV-1 and HIV-2, hepatitis B virus and hepatitis C virus in blood donations.

More articles on supply chain:

FDA warns hospitals about St. Louis devicemaker selling unapproved devices
The new Mylan? Senators call out Ariad for high price of leukemia drug
Medical device execs call for quicker coverage decisions from CMS

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.